Comparative effectiveness of teriflunomide and dimethyl fumarate
Mathias Due Buron(Rigshospitalet), Melinda Magyari(University of Copenhagen), Matthias Kant(Sygehus Sønderjylland), Anna Tsakiri(University of Southern Denmark), Zsolt Illés(Universität Hamburg), Peter Vestergaard Rasmussen(Aarhus University Hospital), J. Zs. Mezei(University of Southern Denmark), Monika Katarzyna Góra(University of Southern Denmark), Homayoun Roshanisefat(University of Southern Denmark), Per Soelberg Sørensen(University of Copenhagen), Tobias Sejbæk(University of Southern Denmark), Arkadiusz Wêglewski(Rigshospitalet), Thor Petersen(Aarhus University Hospital), Thor Ameri Chalmer(Rigshospitalet), Houry Hassanpour-Kalam-Roudy(University of Southern Denmark), Finn Sellebjerg(Danish Multiple Sclerosis Center)
Cited by 45
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Multiple Sclerosis Severity Score
|Neurology|2005|957